Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Farmers Insurance
Express Scripts
Cantor Fitzgerald
Chinese Patent Office
Federal Trade Commission

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 064096

« Back to Dashboard

NDA 064096 describes AKTOB, which is a drug marketed by Akorn and is included in one NDA. It is available from seven suppliers. Additional details are available on the AKTOB profile page.

The generic ingredient in AKTOB is tobramycin. There are eighteen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the tobramycin profile page.

Summary for 064096

Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 064096


Medical Subject Heading (MeSH) Categories for 064096

Suppliers and Packaging for NDA: 064096

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AKTOB tobramycin SOLUTION/DROPS;OPHTHALMIC 064096 ANDA Henry Schein Inc. 0404-7196 0404-7196-01 1 BOTTLE, DROPPER in 1 CARTON (0404-7196-01) > 5 mL in 1 BOTTLE, DROPPER
AKTOB tobramycin SOLUTION/DROPS;OPHTHALMIC 064096 ANDA Blenheim Pharmacal, Inc. 10544-883 10544-883-99 1 BOTTLE, DROPPER in 1 CARTON (10544-883-99) > 5 mL in 1 BOTTLE, DROPPER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength0.3%
Approval Date:Jan 31, 1996TE:ATRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Boehringer Ingelheim
Farmers Insurance
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: